Patient compliance with drug therapy for diabetic nephropathy

D Hughes, B Manns - CMAJ, 2000 - Can Med Assoc
First, it was assumed that noncompliers lose renal function at the same rate as patients in
the placebo arm of a diabetic nephropathy trial comparing the effects of ACE inhibitors and …

Treating diabetic nephropathy: unfinished success is not failure

J Lewis - Clinical Journal of the American Society of Nephrology, 2007 - journals.lww.com
An irrefutable body of evidence from multiple well-powered clinical trials and numerous
clinical studies in patients with type 1 and type 2 diabetes mellitus (DM) has demonstrated …

Adherence to vascular protection drugs in diabetic patients in Quebec: a population-based analysis

S Asghari, J Courteau, C Drouin… - Diabetes and …, 2010 - journals.sagepub.com
The purpose of this study was to assess adherence to vascular protection drugs in diabetic
patients using a cohort of diabetic patients aged≥ 30 years, covered by the public drug …

[PDF][PDF] Compliance in hypertension: why don't patients take their pills?

MG Myers - Cmaj, 1999 - Can Med Assoc
There is no longer any doubt that treating hyper-tensive patients can reduce the incidence of
heart attack and stroke. One would think that by now most Canadians with hypertension …

Compliance with pharmacological therapy in hypertension: can we do better, and how?

G Thrall, GYH Lip, D Lane - Journal of Human Hypertension, 2004 - nature.com
Noncompliance with treatment has long been the plague of the national health-care system.
Each year it is estimated that noncompliance with medication costs the UK economy billions …

Noncompliance may cause half of antihypertensive drug failures

J Stephenson - Jama, 1999 - jamanetwork.com
Pressure, pharmacological therapy for uncontrolled blood pressure should proceed in
stepwise fashion. The physician usually prescribes a low dosage of a diuretic or ß-blocker …

Measuring, analyzing, and managing drug adherence in resistant hypertension

M Burnier, G Wuerzner, H Struijker-Boudier… - …, 2013 - Am Heart Assoc
One of the main reasons why drug adherence remains generally ignored, outside of clinical
trials and prospective surveys, is the lack of reliable, easy to use, and economical methods …

End‐stage renal disease and adherence to angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers among patients with diabetes

M Shani, S Vinker, L Feldman - The Journal of Clinical …, 2017 - Wiley Online Library
Angiotensin‐converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARB
s) have become standards of care for diabetic nephropathy. The authors assessed the …

The need to assess adherence in apparent treatment resistant hypertension

M Siddiqui, P Muntner - American Journal of Hypertension, 2023 - academic.oup.com
A 2008 Scientific Statement from the American Heart Association defined resistant
hypertension as blood pressure (BP) that remains above goal despite the concurrent use of …

Effect of partial compliance on cardiovascular medication effectiveness

JA Cramer - Heart, 2002 - heart.bmj.com
The typical assessment of mediation compliance by physicians is similar to the assessment
of an iceberg from the ship captain's window. The difference is that when a captain sees ice …